Literature DB >> 11089618

Modeling HIV transfer between dendritic cells and T cells: importance of HIV phenotype, dendritic cell-T cell contact and T-cell activation.

G Vanham1, L Penne, H Allemeersch, L Kestens, B Willems, G van der Groen, K T Jeang, Z Toossi, E Rich.   

Abstract

OBJECTIVE: To study the requirements for HIV transfer between dendritic cells (DC) and CD4 T cells, using an in vitro model, combined with flow cytometry.
METHODS: Immature DC and macrophages (MA) were generated from monocytes. After infection, DC or MA were cultured alone or with purified CD4 T cells. Intracellular HIV was measured, using (1) the monocyte (MO)-tropic AD8 HIV, endowed with enhanced green fluorescent protein (EGFP); and (2) intracellular staining of laboratory HIV strains and clones from primary isolates.
RESULTS: (1) Clone AD8-EGFP infected DC and MA with equal efficiency, but the virus was preferentially transferred from DC to autologous T cells. (2) DC were more productively infected with R5/NSI, as compared to X4/SI, HIV, but both HIV phenotypes were easily transmitted to autologous T4 cells. (3) HIV-infected DC transferred the virus to T cells across a semi-permeable membrane, if the T cells were in contact with non-infected DC. (4) Co-culture of T cells with autologous non-infected DC induced T-cell activation. HIV-infected DC selectively increased HLA-DR on T cells and HLA-DR (+) T cells were preferential targets for HIV transfer. (5) Resting Ba-L-infected CD4 T cells were able to transmit the virus 'inversely' to co-cultured DC.
CONCLUSION: HIV transfer between monocyte-derived dendritic cells and autologous CD4 T cells was directly demonstrated using flow cytometry. The transfer proceeded in both directions, depended on cellular contact and was associated with partial T-cell activation. This model, representing relevant in vivo targets of HIV, is useful to further investigate interactions between HIV, DC and T cells, without the need for primary ex vivo DC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11089618     DOI: 10.1097/00002030-200010200-00011

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  12 in total

1.  Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine.

Authors:  José das Neves; Johan Michiels; Kevin K Ariën; Guido Vanham; Mansoor Amiji; Maria Fernanda Bahia; Bruno Sarmento
Journal:  Pharm Res       Date:  2011-11-10       Impact factor: 4.200

2.  Long-term productive human immunodeficiency virus infection of CD1a-sorted myeloid dendritic cells.

Authors:  Sergei Popov; Agnès-Laurence Chenine; Andreas Gruber; Pei-Lin Li; Ruth M Ruprecht
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Expression of a protein phosphatase 1 inhibitor, cdNIPP1, increases CDK9 threonine 186 phosphorylation and inhibits HIV-1 transcription.

Authors:  Tatiana Ammosova; Venkat R K Yedavalli; Xiaomei Niu; Marina Jerebtsova; Aleyde Van Eynde; Monique Beullens; Mathieu Bollen; Kuan-Teh Jeang; Sergei Nekhai
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

4.  Diversity of HIV-1 subtype B: implications to the origin of BF recombinants.

Authors:  Elcio Leal; Fabiola E Villanova
Journal:  PLoS One       Date:  2010-07-28       Impact factor: 3.240

5.  The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates.

Authors:  Kevin K Ariën; Awet Abraha; Miguel E Quiñones-Mateu; Luc Kestens; Guido Vanham; Eric J Arts
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Activation of P-TEFb at sites of dual HIV/TB infection, and inhibition of MTB-induced HIV transcriptional activation by the inhibitor of CDK9, Indirubin-3'-monoxime.

Authors:  Zahra Toossi; Mianda Wu; Christina S Hirsch; Harriet Mayanja-Kizza; Joy Baseke; Htin Aung; David H Canaday; Koh Fujinaga
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-06       Impact factor: 2.205

7.  Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells.

Authors:  John R Mascola; Mark K Louder; Christine Winter; Ranjani Prabhakara; Stephen C De Rosa; Daniel C Douek; Brenna J Hill; Dana Gabuzda; Mario Roederer
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides.

Authors:  Yven Van Herrewege; Guido Vanham; Jo Michiels; Katrien Fransen; Luc Kestens; Koen Andries; Paul Janssen; Paul Lewi
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  Efficient replication of human immunodeficiency virus type 1 in resting CD4+ T lymphocytes is induced by coculture with autologous dendritic cells in the absence of foreign antigens.

Authors:  Corinne Barat; Caroline Gilbert; Michel J Tremblay
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

Review 10.  Syphilis and human immunodeficiency virus co-infection.

Authors:  Allen S Funnyé; Abbasi J Akhtar
Journal:  J Natl Med Assoc       Date:  2003-05       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.